Eitan Friedman
Impact in
- Reproductive Medicine top 0.2%
- Ovarian cancer diagnosis and treatment
- Genetics top 0.1%
- BRCA gene mutations in cancer
Papers in
- Genetics 190
- BRCA gene mutations in cancer 146
-
- Cancer Genomics and Diagnostics 60
- Co-authors
- Samuel GershonPablo V. GejmanAllen M. SpiegelLee S. WeinsteinHoau-Yan WangMaria J. MerinoAndrew ShenkerEphrat Levy‐Lahad
- Journals
- Breast Cancer Research and Treatment (28 papers)Familial Cancer (14 papers)British Journal of Cancer (14 papers)European Journal of Pharmacology (12 papers)Journal of Pharmacology and Experimental Therapeutics (12 papers)
- Partner nations
- IsraelUnited StatesBrazil
In The Last Decade
Eitan Friedman
469 papers receiving 16.5k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Reproductive Medicine 1.6k
- Genetics 5.1k
- Cellular and Molecular Neuroscience 3.1k
- Cancer Research 2.4k
- Oncology 3.3k
Countries citing papers authored by Eitan Friedman
This map shows the geographic impact of Eitan Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eitan Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eitan Friedman more than expected).
Fields of papers citing papers by Eitan Friedman
This network shows the impact of papers produced by Eitan Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eitan Friedman. The network helps show where Eitan Friedman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eitan Friedman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 3 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 14 | |
| 6 | Local microRNA delivery targets Palladin and prevents metastatic breast cancer | 2016 | 1 |
| 7 | 2014 | 0 | |
| 8 | 2013 | 8 | |
| 9 | 2012 | 43 | |
| 10 | 2007 | 242 | |
| 11 | 2006 | 10 | |
| 12 | 2006 | 6 | |
| 13 | 2002 | 1 | |
| 14 | 2002 | 15 | |
| 15 | 2001 | 13 | |
| 16 | 2001 | 22 | |
| 17 | 2000 | 31 | |
| 18 | 2000 | 10 | |
| 19 | [Experience at Sheba Hospital in oncogenetic counseling and genetic testing of women with a high risk for breast and ovarian cancer]. | 1998 | 0 |
| 20 | Handbook of pharmacology of aging | 1996 | 13 |
About Eitan Friedman
Eitan Friedman is a scholar working on Genetics, Cancer Research, Reproductive Medicine, Cellular and Molecular Neuroscience and Pathology and Forensic Medicine, having authored 484 papers that have together received 17.1k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (146 papers), Cancer Genomics and Diagnostics (60 papers), DNA Repair Mechanisms (59 papers), Neurotransmitter Receptor Influence on Behavior (47 papers), Neuroscience and Neuropharmacology Research (42 papers), Genetic factors in colorectal cancer (42 papers), Ovarian cancer diagnosis and treatment (38 papers) and Receptor Mechanisms and Signaling (36 papers). The work is most often cited by research in Reproductive Medicine (1.6k citations), Genetics (5.1k citations), Cellular and Molecular Neuroscience (3.1k citations), Cancer Research (2.4k citations) and Oncology (3.3k citations). Eitan Friedman has collaborated with scholars based in Israel, United States and Brazil. Frequent co-authors include Samuel Gershon, Pablo V. Gejman, Allen M. Spiegel, Lee S. Weinstein, Hoau-Yan Wang, Maria J. Merino, Andrew Shenker, Ephrat Levy‐Lahad, H Y Wang and Steven A. Narod. Their work appears in journals such as Breast Cancer Research and Treatment, Familial Cancer, British Journal of Cancer, European Journal of Pharmacology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.